|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: European Organisation for Research and Treatment of
Cancer Brain Tumor and Radiotherapy Groups; National Cancer
Institute of Canada Clinical Trials Group: Radiotherapy plus
concomitant and adjuvant temozolomide for glioblastoma. N Engl J
Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bauman GS, Sneed PK, Wara WM, Stalpers LJ,
Chang SM, McDermott MW, Gutin PH and Larson DA: Reirradiation of
primary CNS tumors. Int J Radiat Oncol Biol Phys. 36:433–441. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Combs SE, Gutwein S, Thilmann Ch, Huber P,
Debus J and Schulz-Ertner D: Stereotactically guided fractionated
re-irradiation in recurrent glioblastoma multiforme. J Neurooncol.
74:167–171. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Voynov G, Kaufman S, Hong T, Pinkerton A,
Simon R and Dowsett R: Treatment of recurrent malignant gliomas
with stereotactic intensity modulated radiation therapy. Am J Clin
Oncol. 25:606–611. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim B, Soisson E, Duma C, Chen P, Hafer R,
Cox C, Cubellis J, Minion A, Plunkett M and Mackintosh R: Treatment
of recurrent high grade gliomas with hypofractionated stereotactic
image-guided helical tomotherapy. Clin Neurol Neurosurg.
113:509–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McKenzie JT, Guarnaschelli JN, Vagal AS,
Warnick RE and Breneman JC: Hypofractionated stereotactic
radiotherapy for unifocal and multifocal recurrence of malignant
gliomas. J Neurooncol. 113:403–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fokas E, Wacker U, Gross MW, Henzel M,
Encheva E and Engenhart-Cabillic R: Hypofractionated stereotactic
reirradiation of recurrent glioblastomas: A beneficial treatment
option after high-dose radiotherapy? Strahlenther Onkol.
185:235–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Archavlis E, Tselis N, Birn G, Ulrich P,
Baltas D and Zamboglou N: Survival analysis of HDR brachytherapy
versus reoperation versus temozolomide alone: A retrospective
cohort analysis of recurrent glioblastoma multiforme. BMJ Open.
3:e0022622013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Combs SE, Gutwein S, Thilmann C, Debus J
and Schulz-Ertner D: Reirradiation of recurrent WHO grade III
astrocytomas using fractionated stereotactic radiotherapy (FSRT).
Strahlenther Onkol. 181:768–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vordermark D, Kölbl O, Ruprecht K, Vince
GH, Bratengeier K and Flentje M: Hypofractionated stereotactic
re-irradiation: Treatment option in recurrent malignant glioma. BMC
Cancer. 5:552005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Henke G, Paulsen F, Steinbach JP,
Ganswindt U, Isijanov H, Kortmann RD, Bamberg M and Belka C:
Hypofractionated reirradiation for recurrent malignant glioma.
Strahlenther Onkol. 185:113–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Elliott RE, Parker EC, Rush SC, Kalhorn
SP, Moshel YA, Narayana A, Donahue B and Golfinos JG: Efficacy of
gamma knife radiosurgery for small-volume recurrent malignant
gliomas after initial radical resection. World Neurosurg.
76:128–140; discussion 61-62. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cuneo KC, Vredenburgh JJ, Sampson JH,
Reardon DA, Desjardins A, Peters KB, Friedman HS, Willett CG and
Kirkpatrick JP: Safety and efficacy of stereotactic radiosurgery
and adjuvant bevacizumab in patients with recurrent malignant
gliomas. Int J Radiat Oncol Biol Phys. 82:2018–2024. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Larson DA, Suplica JM, Chang SM, Lamborn
KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK and
Berger MS: Permanent iodine 125 brachytherapy in patients with
progressive or recurrent glioblastoma multiforme. Neuro Oncol.
6:119–126. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Darakchiev BJ, Albright RE, Breneman JC
and Warnick RE: Safety and efficacy of permanent iodine-125 seed
implants and carmustine wafers in patients with recurrent
glioblastoma multiforme. J Neurosurg. 108:236–242. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cannon GM, Tomé WA, Robins HI and Howard
SP: Pulsed reduced dose-rate radiotherapy: Case report: A novel
re-treatment strategy in the management of recurrent glioblastoma
multiforme. J Neurooncol. 83:307–311. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pellettieri L, HStenstam B, Rezaei A,
Giusti V and Sköld K: An investigation of boron neutron capture
therapy for recurrent glioblastoma multiforme. Acta Neurol Scand.
117:191–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho KH, Hall WA, Gerbi BJ, Higgins PD,
McGuire WA and Clark HB: Single dose versus fractionated
stereotactic radiotherapy for recurrent high-grade gliomas. Int J
Radiat Oncol Biol Phys. 45:1133–1141. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Combs SE, Thilmann C, Edler L, Debus J and
Schulz-Ertner D: Efficacy of fractionated stereotactic
reirradiation in recurrent gliomas: Long-term results in 172
patients treated in a single institution. J Clin Oncol.
23:8863–8869. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Combs SE, Bischof M, Welzel T, Hof H,
Oertel S, Debus J and Schulz-Ertner D: Radiochemotherapy with
temozolomide as re-irradiation using high precision fractionated
stereotactic radiotherapy (FSRT) in patients with recurrent
gliomas. J Neurooncol. 89:205–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
MaierHauff K, Ulrich F, Nestler D, Niehoff
H, Wust P, Thiesen B, Orawa H, Budach V and Jordan A: Efficacy and
safety of intratumoral thermotherapy using magnetic iron-oxide
nanoparticles combined with external beam radiotherapy on patients
with recurrent glioblastoma multiforme. J Neurooncol. 103:317–324.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Minniti G, Armosini V, Salvati M, Lanzetta
G, Caporello P, Mei M, Osti MF and Maurizi RE: Fractionated
stereotactic reirradiation and concurrent temozolomide in patients
with recurrent glioblastoma. J Neurooncol. 103:683–691. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hundsberger T, Brügge D, Putora PM, Weder
P, Weber J and Plasswilm L: Re-irradiation with and without
bevacizumab as salvage therapy for recurrent or progressive
high-grade gliomas. J Neurooncol. 112:133–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Flieger M, Ganswindt U, Schwarz SB, Kreth
FW, Tonn JC, la Fougère C, Ertl L, Linn J, Herrlinger U, Belka C
and Niyazi M: Re-irradiation and bevacizumab in recurrent
high-grade glioma: An effective treatment option. J Neurooncol.
117:337–345. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liem B J, Holland J M, Kang M Y, Hoffelt
SC and Marquez CM: Karnofsky Performance Status assessment:
Resident versus attending. J Cancer Educ. 17:138–141.
2002.PubMed/NCBI
|
|
29
|
Chinot OL, Wick W and Cloughesy T:
Bevacizumab for newly diagnosed glioblastoma. N Engl J Med.
370:20492014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shepherd SF, Laing RW, Cosgrove VP,
Warrington AP, Hines F, Ashley SE and Brada M: Hypofractionated
stereotactic radiotherapy in the management of recurrent glioma.
Int J Radiat Oncol Biol Phys. 37:393–398. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grosu AL, Weber WA, Franz M, Stärk S,
Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M and Nieder C:
Reirradiation of recurrent high-grade gliomas using amino acid PET
(SPECT)/CT/MRI image fusion to determine gross tumor volume for
stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol
Phys. 63:511–519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
ErnstStecken A, Ganslandt O, Lambrecht U,
Sauer R and Grabenbauer G: Survival and quality of life after
hypofractionated stereotactic radiotherapy for recurrent malignant
glioma. J Neurooncol. 81:287–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gutin PH, Iwamoto FM, Beal K, Mohile NA,
Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J and Abrey LE:
Safety and efficacy of bevacizumab with hypofractionated
stereotactic irradiation for recurrent malignant gliomas. Int J
Radiat Oncol Biol Phys. 75:156–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Patel M, Siddiqui F, Jin JY, Mikkelsen T,
Rosenblum M, Movsas B and Ryu S: Salvage reirradiation for
recurrent glioblastoma with radiosurgery: Radiographic response and
improved survival. J Neurooncol. 92:185–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fogh SE, Andrews DW, Glass J, Curran W,
Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B, et al:
Hypofractionated stereotactic radiation therapy: An effective
therapy for recurrent high-grade gliomas. J Clin Oncol.
28:3048–3053. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Minniti G, Scaringi C, De Sanctis V,
Lanzetta G, Falco T, Di Stefano D, Esposito V and Enrici RM:
Hypofractionated stereotactic radiotherapy and continuous low-dose
temozolomide in patients with recurrent or progressive malignant
gliomas. J Neurooncol. 111:187–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shapiro LQ, Beal K, Goenka A, Karimi S,
Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE and Gutin PH:
Patterns of failure after concurrent bevacizumab and
hypofractionated stereotactic radiation therapy for recurrent
high-grade glioma. Int J Radiat Oncol Biol Phys. 85:636–642. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wuthrick EJ, Curran WJ Jr, Camphausen K,
Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik
M, et al: A pilot study of hypofractionated stereotactic radiation
therapy and sunitinib in previously irradiated patients with
recurrent high-grade glioma. Int J Radiat Oncol Biol Phys.
90:369–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chalmers AJ, Ruff EM, Martindale C,
Lovegrove N and Short SC: Cytotoxic effects of temozolomide and
radiation are additive- and schedule-dependent. Int J Radiat Oncol
Biol Phys. 75:1511–1519. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Den RB, Kamrava M, Sheng Z, WernerWasik M,
Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T,
Andrews DW, et al: A phase I study of the combination of sorafenib
with temozolomide and radiation therapy for the treatment of
primary and recurrent high-grade gliomas. Int J Radiat Oncol Biol
Phys. 85:321–328. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shrieve DC, Alexander E III, Wen PY, Fine
HA, Kooy HM, Black PM and Loeffler JS: Comparison of stereotactic
radiosurgery and brachytherapy in the treatment of recurrent
glioblastoma multiforme. Neurosurgery. 36:275–284. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hall WA, Djalilian HR, Sperduto PW, Cho
KH, Gerbi BJ, Gibbons JP, Rohr M and Clark HB: Stereotactic
radiosurgery for recurrent malignant gliomas. J Clin Oncol.
13:1642–1648. 1995.PubMed/NCBI
|
|
43
|
Combs SE, Widmer V, Thilmann C, Hof H,
Debus J and Schulz-Ertner D: Stereotactic radiosurgery (SRS):
Treatment option for recurrent glioblastoma multiforme (GBM).
Cancer. 104:2168–2173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Maranzano E, Anselmo P, Casale M, Trippa
F, Carletti S, Principi M, Loreti F, Italiani M and Caserta C:
Treatment of recurrent glioblastoma with stereotactic radiotherapy:
Long-term results of a mono-institutional trial. Tumori. 97:56–61.
2011.PubMed/NCBI
|
|
45
|
Torok JA, Wegner RE, Mintz AH, Heron DE
and Burton SA: Re-irradiation with radiosurgery for recurrent
glioblastoma multiforme. Technol Cancer Res Treat. 10:253–258.
2011.PubMed/NCBI
|
|
46
|
Conti A, Pontoriero A, Arpa D, Siragusa C,
Tomasello C, Romanelli P, Cardali S, Granata F, De Renzis C and
Tomasello F: Efficacy and toxicity of CyberKnife re-irradiation and
‘dose dense’ temozolomide for recurrent gliomas. Acta Neurochir
(Wien). 154:203–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Skeie BS, Enger PØ, Brøgger J, Ganz JC,
Thorsen F, Heggdal JI and Pedersen PH: γknife surgery versus
reoperation for recurrent glioblastoma multiforme. World Neurosurg.
78:658–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cabrera AR, Cuneo KC, Desjardins A,
Sampson JH, McSherry F, Herndon JE II, Peters KB, Allen K, Hoang
JK, Chang Z, et al: Concurrent stereotactic radiosurgery and
bevacizumab in recurrent malignant gliomas: A prospective trial.
Int J Radiat Oncol Biol Phys. 86:873–879. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Martínez-Carrillo M, Tovar-Martín I,
Zurita-Herrera M, Del Moral-Ávila R, Guerrero-Tejada R, Saura-Rojas
E, Osorio-Ceballos JL, Arrebola-Moreno JP and Expósito-Hernández J:
Salvage radiosurgery for selected patients with recurrent malignant
gliomas. Biomed Res Int. 2014:6579532014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mayer R and Sminia P: Reirradiation
tolerance of the human brain. Int J Radiat Oncol Biol Phys.
70:1350–1360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Simon JM, Cornu P, Boisserie G, Hasboun D,
Tep B, Hardiman C, Valery CA, Delattre JY, Dormont D, Baillet F and
Mazeron JJ: Brachytherapy of glioblastoma recurring in previously
irradiated territory: Predictive value of tumor volume. Int J
Radiat Oncol Biol Phys. 53:67–74. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Barani IJ and Larson DA: Radiation therapy
of glioblastoma. Cancer Treat Res. 163:49–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tatter SB, Shaw EG, Rosenblum ML, Karvelis
KC, Kleinberg L, Weingart J, Olson JJ, Crocker IR, Brem S, Pearlman
JL, et al: An inflatable balloon catheter and liquid 125I radiation
source (GliaSite Radiation Therapy System) for treatment of
recurrent malignant glioma: Multicenter safety and feasibility
trial. J Neurosurg. 99:297–303. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chan TA, Weingart JD, Parisi M, Hughes MA,
Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD and
Kleinberg L: Treatment of recurrent glioblastoma multiforme with
GliaSite brachytherapy. Int J Radiat Oncol Biol Phys. 62:1133–1139.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gabayan AJ, Green SB, Sanan A, Jenrette J,
Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, et
al: GliaSite brachytherapy for treatment of recurrent malignant
gliomas: A retrospective multi-institutional analysis.
Neurosurgery. 58:701–709. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tselis N, Kolotas C, Birn G, Röddiger S,
Filipowicz I, Kontova M, Fountzilas G, Selviaridis P, Baltas D,
Heyd R, et al: CT-guided interstitial HDR brachytherapy for
recurrent glioblastoma multiforme. Long-term results. Strahlenther
Onkol. 183:563–570. 2007. View Article : Google Scholar
|
|
57
|
Fabrini MG, Perrone F, De Franco L,
Pasqualetti F, Grespi S, Vannozzi R and Cionini L: Perioperative
high-dose-rate brachytherapy in the treatment of recurrent
malignant gliomas. Strahlenther Onkol. 185:524–529. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kickingereder P, Hamisch C, Suchorska B,
Galldiks N, VisserVandewalle V, Goldbrunner R, Kocher M, Treuer H,
Voges J and Ruge MI: Low-dose rate stereotactic iodine-125
brachytherapy for the treatment of inoperable primary and recurrent
glioblastoma: Single-center experience with 201 cases. J
Neurooncol. 120:615–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gregg EC, Yau TM and Kim SC: Effect of low
dose rate radiation on cell growth kinetics. Biophys J. 28:81–91.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Koot RW, Maarouf M, Hulshof MC, Voges J,
Treuer H, Koedooder C, Sturm V and Bosch DA: Brachytherapy: Results
of two different therapy strategies for patients with primary
glioblastoma multiforme. Cancer. 88:2796–2802. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Archavlis E, Tselis N, Birn G, Ulrich P
and Zamboglou N: Salvage therapy for recurrent glioblastoma
multiforme: A multimodal approach combining fluorescence-guided
resurgery, interstitial irradiation and chemotherapy. Neurol Res.
36:1047–1055. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Adkison JB, Tomé W, Seo S, Richards GM,
Robins HI, Rassmussen K, Welsh JS, Mahler PA and Howard SP:
Reirradiation of large-volume recurrent glioma with pulsed
reduced-dose-rate radiotherapy. Int J Radiat Oncol Biol Phys.
79:835–841. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mishima Y, Honda C, Ichihashi M, Obara H,
Hiratsuka J, Fukuda H, Karashima H, Kobayashi T, Kanda K and
Yoshino K: Treatment of malignant melanoma by single thermal
neutron capture therapy with melanoma-seeking 10B-compound. Lancet.
2:388–389. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sun T, Zhang Z, Li B, Chen G, Xie X, Wei
Y, Wu J, Zhou Y and Du Z: Boron neutron capture therapy induces
cell cycle arrest and cell apoptosis of glioma stem/progenitor
cells in vitro. Radiat Oncol. 8:1952013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Miyatake S, Kawabata S, Yokoyama K,
Kuroiwa T, Michiue H, Sakurai Y, Kumada H, Suzuki M, Maruhashi A,
Kirihata M and Onoc K: Survival benefit of boron neutron capture
therapy for recurrent malignant gliomas. Appl Radiat Isot. 67(7-8
Suppl): S22–S24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Miyatake S, Kawabata S, Hiramatsu R,
Furuse M, Kuroiwa T and Suzuki M: Boron neutron capture therapy
with bevacizumab may prolong the survival of recurrent malignant
glioma patients: Four cases. Radiat Oncol. 9:62014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
DeBin JA, Maggio JE and Strichartz GR:
Purification and characterization of chlorotoxin, a chloride
channel ligand from the venom of the scorpion. Am J Physiol.
264:C361–C369. 1993.PubMed/NCBI
|
|
68
|
Mamelak AN, Rosenfeld S, Bucholz R,
Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher
D, Liu A, et al: Phase I single-dose study of
intracavitary-administered iodine-131-TM-601 in adults with
recurrent high-grade glioma. J Clin Oncol. 24:3644–3650. 2006.
View Article : Google Scholar : PubMed/NCBI
|
